论文部分内容阅读
目的:探讨培菲康对菌群失调性腹泻的疗效。方法:选择60例菌群失调性腹泻患者,按随机抽样法将病人分为2组,分别给予培菲康、乳酶生治疗,疗程14天。疗效判断为显效、有效和无效。结果经治疗后,培菲康组总有效率为93.33%,对照组总有效率为63.33%,结论:培菲康具有提供营养、增强免疫力,阻止条件致病菌及毒素对肠粘膜上皮的粘附,调整肠道菌群平衡的作用,是治疗菌群失调性腹泻的有效制剂。
Objective: To investigate the effect of peflokac on bacterial imbalance diarrhea. Methods: Sixty patients with dysbacteriosis diarrhea were selected. The patients were divided into two groups according to the random sampling method. The patients were treated with pefloxacin and lactalbumin respectively for 14 days. The curative effect is markedly effective, effective and ineffective. Results After treatment, the total effective rate was 93.33% in the Pefikang group and 63.33% in the control group. Conclusion: Pefikan can provide nutrition, enhance immunity and prevent the pathogenic bacteria and toxins from affecting the intestinal mucosal epithelium Adhesion, adjust the role of intestinal flora balance, is an effective treatment of flora imbalance diarrhea.